Journal
CURRENT HYPERTENSION REPORTS
Volume 18, Issue 10, Pages -Publisher
SPRINGER
DOI: 10.1007/s11906-016-0680-3
Keywords
Antihypertensive therapy; Blood pressure; Variability in blood pressure; BPV
Categories
Ask authors/readers for more resources
Purpose of Review The study aims to summarize the effect of antihypertensive therapy on various types of BP variability in hypertensives. Recent Findings Visit-to-visit, day-by-day, and ambulatory BPV are markers of target organ damage and cardiovascular prognosis, as was shown in the LIFE study, which showed that visit-to-visit variability in BP predicted cardiovascular events in treated hypertensive patients with left ventricular hypertrophy. Long-acting calcium channel blockers (CCBs) may be a preferable treatment in reducing BPV measures. Nonadherence to antihypertensive medication is also a very important component of increased BPV, and improving the adherence is also a key for the favorable prognosis. Summary BPV cannot be a target of antihypertensive treatments because of the lack of definitive evidence. However, in high-risk patients, those with cardiovascular or cerebrovascular diseases, the clinical significance should be considered in individual basis. Especially, reduction of BPV would be an important strategy for these patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available